advertisement
De Moraes CG 26
Showing records 1 to 25 | Display all abstracts from De Moraes CG108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
Tsamis E; Tsamis E
Translational vision science & technology 2023; 12: 19
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Jackson AB
Ophthalmology 2023; 130: 462-468
107572 Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial
Hark LA
American Journal of Ophthalmology 2023; 251: 12-23
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
Tsamis E
Translational vision science & technology 2023; 12: 19
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Martin KR
Ophthalmology 2023; 130: 462-468
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
La Bruna S
Translational vision science & technology 2023; 12: 19
107572 Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial
Horowitz JD; Gorroochurn P
American Journal of Ophthalmology 2023; 251: 12-23
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Coote MA
Ophthalmology 2023; 130: 462-468
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
Rai A; Rai A
Translational vision science & technology 2023; 12: 19
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Medeiros FA
Ophthalmology 2023; 130: 462-468
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
Leshno A
Translational vision science & technology 2023; 12: 19
107572 Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial
Park L
American Journal of Ophthalmology 2023; 251: 12-23
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
Grossman J
Translational vision science & technology 2023; 12: 19
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Girkin CA
Ophthalmology 2023; 130: 462-468
107572 Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial
Wang Q; Diamond DF
American Journal of Ophthalmology 2023; 251: 12-23
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Fazio MA
Ophthalmology 2023; 130: 462-468
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
Cioffi G; Liebmann JM
Translational vision science & technology 2023; 12: 19
107572 Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial
Harizman N
American Journal of Ophthalmology 2023; 251: 12-23
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Liebmann JM; De Moraes CG
Ophthalmology 2023; 130: 462-468
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
De Moraes CG
Translational vision science & technology 2023; 12: 19
107572 Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial
Auran JD; Maruri SC
American Journal of Ophthalmology 2023; 251: 12-23
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Weinreb RN
Ophthalmology 2023; 130: 462-468
108151 Progression of Early Glaucomatous Damage: Performance of Summary Statistics From Optical Coherence Tomography and Perimetry
Hood DC
Translational vision science & technology 2023; 12: 19
107572 Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial
Henriquez DR
American Journal of Ophthalmology 2023; 251: 12-23
107576 Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss
Zangwill LM; Wu Z
Ophthalmology 2023; 130: 462-468
